Publications by authors named "W Christopher C Ehmann"

Claim this Profile
C
Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity.
Chenchen Zhao, Bei Jia, Yixing Jiang, Hiroko Shike, Charyguly Annageldiyev, WChristopher Ehmann

Cancer Immunol Immunother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma.
Jeffrey J Pu, Kristin N Berger, Chunlei Zheng, Nhan Do, David F Claxton, W Christopher Ehmann

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.
Bei Jia, Chenchen Zhao, Kentaro Minagawa, Hiroko Shike, David F Claxton, W Christopher Ehmann

J Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD26PD-1 CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.
Huarong Zhou, Bei Jia, Charyguly Annageldiyev, Kentaro Minagawa, Chenchen Zhao, W Christopher Ehmann

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IMPROVE-BMT: a protocol for a pilot randomised controlled trial of prehabilitation exercise for adult haematopoietic stem cell transplant recipients.
Melanie Potiaumpai, Kathryn H Schmitz, Shin Mineishi, Seema Naik, Baldeep Wirk, W Christopher Ehmann

BMJ Open· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis